Black Friday Get Elite for just $149.00 Claim Now

GENENTA SCIENCE SPA

Contributing Author

Recent Articles by GENENTA SCIENCE SPA

Nov-02	Genenta Unveils Saentra Forge as Its New Brand, Advancing Its Transformation into a Strategic Industrial Platform GlobeNewswire
Oct-21	Genenta Science Announces Receipt of Nasdaq Minimum Bid Price Deficiency Notification GlobeNewswire
Sep-15	Sophia High Tech Flight Hardware on Board VEGA-C VV30 as the European Launcher Carries Sentinel-3C and FLEX into Orbit GlobeNewswire
Jul-23	Genenta-backed Sophia High Tech Brings Aerospace Precision Inside a Nuclear Fusion Reactor with ROMAN, a Robotic Arm GlobeNewswire
Jul-22	Genenta-Backed Sophia High Tech Reports Fiscal Year 2025 Results GlobeNewswire
Apr-23	Genenta signs Definitive Agreements with Sophia High Tech GlobeNewswire
Mar-27	Genenta, evolving into Saentra Forge, has signed a Binding Offer with Sophia High Tech, an Italian company manufacturing critical parts for Europe's space and defense programs GlobeNewswire
Mar-24	Genenta, evolving into Saentra Forge, continues to evaluate strategic options for its original biotechnology platform derived from the research of Professor Luigi Naldini GlobeNewswire
Mar-13	Genenta, Evolving into Saentra Forge, Announces CEO's Appointment by the Italian Government to the Board of Guarantors of the Italian Academy at Columbia University GlobeNewswire
Feb-27	Genenta Advances Transformation into Saentra Forge, Strengthens ATC Governance and Expands Strategic Industrial Consolidation Platform GlobeNewswire
Jan-27	Genenta Announces Strategic Transformation into a Biotech, Defense, Aerospace, and National Security Industrial Consolidator GlobeNewswire
Dec-19	Genenta Science Provides Update on CEO Ownership GlobeNewswire
Nov-24	Genenta Reports Long-Term Survival Trends and Immune Findings in Brain Tumor (GBM) Trial GlobeNewswire
Oct-26	Genenta Announces Pricing of $15.0 Million Registered Direct Offering of American Depositary Shares GlobeNewswire
Oct-24	Genenta and Anemocyte Announce Strategic Partnership to Advance Off-The-Shelf LVV Plasmid DNA Production GlobeNewswire
Jul-01	Genenta Announces Long-Term Follow-Up Observations in Brain Tumor (GBM) Study with Emerging Survival Signals GlobeNewswire

Affiliate • Advertise • APIs • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)